eli lilly semaglutide drug launches weight-loss Mounjaro in India, beats Novo Nordisk to major market Could Eli Lilly's Next Weight

however, it is well-established that GLP-1 receptors (which semaglutide stimulates) are involved in the regulation of stomach emptying and motility

These symptoms often improve with continued treatment, but persistent or bothersome palpitations warrant clinical evaluation to exclude other causes and assess whether the heart rate increase is excessive

These two medications work in different ways, targeting different parts of the body

Currently, only two GLP-1 medications are FDA-approved for weight loss in adolescents and children: liraglutide and semaglutide

Discover the key differences between Tirzepatide and Semaglutide weight loss treatments